Stock & Company Details
Aprea Therapeutics Inc $APRE
Price:
46,691,331
12M
$9.9M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
APRE technical indicators
Latest Aprea Therapeutics Inc (APRE) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
50.25 4.4%
MACD:
-0.01 17.9%
SMA 50:
$0.84 0.5%
SMA 200:
$0.99 0.4%
EMA 20:
$0.79 0.1%
Bollinger Bands:
0.84 / 0.69
Stochastic:
76.67 2.2%
ADX 14:
15.52 4.0%
ATR 14:
0.08 0.5%
CCI 20:
66.75 21.4%
OBV:
116.69M 0.1%
ROC 12:
3.90% 58.3%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Finance Bot
Ask your questions
Start by typing a question below.
